UPDATE: Canaccord Genuity Reinstates iRhythm Technologies (IRTC) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UPDATE: JPMorgan Upgrades iRhythm Technologies (IRTC) to Overweight
December 17, 2021 3:40 AM EST(Updated - December 17, 2021 4:47 AM EST)
JPMorgan analyst Robbie Marcus upgraded iRhythm Technologies (NASDAQ: IRTC) from Neutral to Overweight with a price target of $116.00 (from $100.00).
The analyst comments "Its not the cleanest story in SMid-cap MedTech, but the risk-reward looks favorable enough for us to upgrade iRhythm to Overweight from Neutral. Even though the... More
